Recombinant Human IL22R Protein，His

The IL-22 receptor (IL-22R) is a crucial component of the immune system, primarily playing a significant role in the regulation of inflammatory responses and tissue homeostasis. IL-22, a cytokine produced by various immune cells, interacts with IL-22R, which is primarily expressed in non-hematopoietic tissues, such as epithelial cells. The IL-22/IL-22R signaling pathway has been implicated in several pathological conditions, including autoimmune diseases, infections, and cancer. Research has revealed that the activation of IL-22R can promote tissue repair and regeneration, particularly in epithelial tissues, suggesting its potential therapeutic roles in managing inflammatory and degenerative diseases. Furthermore, the exploration of IL-22R as a target for novel therapeutics has gained traction, especially in understanding its mechanism of action and the downstream signaling pathways involved. Recombinant proteins of IL-22R have been developed to study its binding affinity, receptor activation, and downstream effects in various biological contexts. These recombinant proteins serve as essential tools for elucidating the role of IL-22R in health and disease, advancing our understanding of immune regulation and offering insights for potential clinical applications in immunotherapy and regenerative medicine. Researchers are increasingly focused on characterizing these recombinant proteins to enhance their efficacy and specificity, thereby contributing to the development of targeted therapies that could manipulate the IL-22 pathway for beneficial outcomes in patients suffering from chronic inflammatory conditions.